Curaleaf Holdings Inc. (CURA) - Total Assets
Based on the latest financial reports, Curaleaf Holdings Inc. (CURA) holds total assets worth CA$2.88 Billion CAD (≈ $2.09 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Curaleaf Holdings Inc. (CURA) shareholders funds for net asset value and shareholders' equity analysis.
Curaleaf Holdings Inc. - Total Assets Trend (2014–2024)
This chart illustrates how Curaleaf Holdings Inc.'s total assets have evolved over time, based on quarterly financial data.
Curaleaf Holdings Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Curaleaf Holdings Inc.'s total assets of CA$2.88 Billion consist of 14.6% current assets and 85.4% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$107.23 Million | 3.2% |
| Accounts Receivable | CA$66.48 Million | 2.3% |
| Inventory | CA$220.65 Million | 7.5% |
| Property, Plant & Equipment | CA$768.11 Million | 26.0% |
| Intangible Assets | CA$1.09 Billion | 36.8% |
| Goodwill | CA$628.88 Million | 21.3% |
Asset Composition Trend (2014–2024)
This chart illustrates how Curaleaf Holdings Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Curaleaf Holdings Inc..
Key Asset Composition Facts
- Current vs. Non-Current Assets: Curaleaf Holdings Inc.'s current assets represent 14.6% of total assets in 2024, a decrease from 88.6% in 2014.
- Cash Position: Cash and equivalents constituted 3.2% of total assets in 2024, down from 66.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 36.8% of total assets.
Curaleaf Holdings Inc. Competitors by Total Assets
Key competitors of Curaleaf Holdings Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.15 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥10.58 Billion |
Curaleaf Holdings Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 1.11 | 1.90 |
| Quick Ratio | 0.71 | 0.51 | 0.79 |
| Cash Ratio | 0.36 | 0.24 | 0.00 |
| Working Capital | CA$141.01 Million | CA$42.96 Million | CA$197.74 Million |
Curaleaf Holdings Inc. - Advanced Valuation Insights
This section examines the relationship between Curaleaf Holdings Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.29 |
| Latest Market Cap to Assets Ratio | 0.76 |
| Asset Growth Rate (YoY) | -4.7% |
| Total Assets | CA$2.95 Billion |
| Market Capitalization | $2.23 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Curaleaf Holdings Inc.'s assets below their book value (0.76x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Curaleaf Holdings Inc.'s assets decreased by 4.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Curaleaf Holdings Inc. (2014–2024)
The table below shows the annual total assets of Curaleaf Holdings Inc. from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$2.95 Billion ≈ $2.13 Billion |
-4.75% |
| 2023-12-31 | CA$3.10 Billion ≈ $2.24 Billion |
-9.31% |
| 2022-12-31 | CA$3.41 Billion ≈ $2.47 Billion |
+9.97% |
| 2021-12-31 | CA$3.11 Billion ≈ $2.25 Billion |
+30.10% |
| 2020-12-31 | CA$2.39 Billion ≈ $1.73 Billion |
+223.86% |
| 2019-12-31 | CA$736.93 Million ≈ $533.08 Million |
+29.32% |
| 2018-12-31 | CA$569.84 Million ≈ $412.21 Million |
+275.88% |
| 2017-12-31 | CA$151.60 Million ≈ $109.67 Million |
+317837.21% |
| 2016-12-31 | CA$47.68K ≈ $34.49K |
-68.57% |
| 2015-12-31 | CA$151.70K ≈ $109.74K |
+84.91% |
| 2014-12-31 | CA$82.04K ≈ $59.34K |
-- |
About Curaleaf Holdings Inc.
Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinct… Read more